Secondary analysis of the STOP-or-NOT trial (2,007 patients having major noncardiac surgery): the risk of intraoperative hypotension with continuing vs stopping RAAS inhibitors varied significantly; higher-risk patients were younger, with higher BMI and haemoglobin.
Secondary analysisn = 2,007
Pirracchio et al. Impact of continuing renin-angiotensin-aldosterone system inhibitors before surgery on intraoperative hypotensive events: a secondary analysis of the STOP-or-NOT Trial